farnesol and Local Neoplasm Recurrence

farnesol has been researched along with Local Neoplasm Recurrence in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Badar, T; Borthakur, G; Cortes, JE; Garcia-Manero, G; Kantarjian, H; O'Brien, S; Ravandi, F; Verstovsek, S	1

Trials

1 trial(s) available for farnesol and Local Neoplasm Recurrence

Article	Year
Phase I study of S-trans, trans-farnesylthiosalicylic acid (salirasib), a novel oral RAS inhibitor in patients with refractory hematologic malignancies. Clinical lymphoma, myeloma & leukemia, 2015, Volume: 15, Issue:7 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Farnesol; Female; Genes, ras; Humans; Leukemia; Male; Middle Aged; Neoplasm Recurrence, Local; raf Kinases; Salicylates; Signal Transduction; Transcriptional Activation; Treatment Outcome	2015

Article

Year

Phase I study of S-trans, trans-farnesylthiosalicylic acid (salirasib), a novel oral RAS inhibitor in patients with refractory hematologic malignancies.

Clinical lymphoma, myeloma & leukemia, 2015, Volume: 15, Issue:7

Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Farnesol; Female; Genes, ras; Humans; Leukemia; Male; Middle Aged; Neoplasm Recurrence, Local; raf Kinases; Salicylates; Signal Transduction; Transcriptional Activation; Treatment Outcome

2015